MAPT and Alzheimer disease: Various neuropathological features, including atrophy, cerebrovascular disruption, and proteinopathy, such as amyloid beta (Aβ), tau, transactive response DNA binding protein of 43 kDa, and α-synuclein, have been observed in AD brains [2].